Objective To appraise the data on systemic adverse effects of inhaled corticosteroids.
Methods A computerized database search from January 1, 1966, through July 31, 1998 …

Inhaled corticosteroids have revolutionized the treatment of asthma and have now become
the mainstay of therapy for patients with chronic disease (1). In a supplement to this journal …

Background Antiinflammatory therapies, such as inhaled corticosteroids or nedocromil, are
recommended for children with asthma, although there is limited information on their long …

In a controlled prospective study we have measured growth and pulmonary function in
children with asthma during long-term treatment with inhaled budesonide and compared …

The article compares the efficacy and safety of inhaled glucocorticosteroids (GCSs) in
patients with asthma. Beclomethasone dipropionate (BDP) is a pro-drug for beclomethasone …

Background Treatment guidelines for asthma recommend inhaled corticosteroids (ICS) as
first‐line therapy for children with persistent asthma. Although ICS treatment is generally …

Inhaled corticosteroids play a pivotal role in the treatment of asthma. Inhalation permits
effective delivery of the corticosteroid in high concentration to target sites within the lung …

Growth retardation is commonly experienced by children who undergo long-term treatment
with glucocorticoids (GC). Whereas most disorders requiring systemic pharmacotherapy (eg …

Background An inhaled glucocorticoid is currently the medication of choice for long-term
control of persistent asthma in children. The role of long-acting β2-adrenergic–receptor …

Intranasal steroids (INSs) are established as first-line treatment for allergic rhinitis. Extensive
use of INSs with few reported adverse events supports the safety of these medications …